Notably, SCF was found to be strongly downregulated in MSCs over all hematological neoplasms, and MSCs derived from myeloid neoplasms exhibited the most pronounced reduced mRNA expression of SCF (Figure 3A). Here, KITLG is linked to hematopoietic and lymphoid system neoplasm.